BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004).-论文-万方医学网

第一作者： John D,Kelly

第一单位： University College London, London, UK. Electronic address: j.d.kelly@ucl.ac.uk.

作者： John D,Kelly ^[1] ; Wei Shen,Tan ^[2] ; Nuria,Porta ^[3] ; Hugh,Mostafid ^[4] ; Robert,Huddart ^[5] ; Andrew,Protheroe ^[6] ; Richard,Bogle ^[7] ; Jane,Blazeby ^[8] ; Alison,Palmer ^[9] ; Jo,Cresswell ^[10] ; Mark,Johnson ^[11] ; Richard,Brough ^[12] ; Sanjeev,Madaan ^[13] ; Stephen,Andrews ^[14] ; Clare,Cruickshank ^[3] ; Stephanie,Burnett ^[3] ; Lauren,Maynard ^[3] ; Emma,Hall ^[3] ; BOXIT Investigators

作者单位： University College London, London, UK. Electronic address: j.d.kelly@ucl.ac.uk. ^[1] University College London, London, UK. ^[2] The Institute of Cancer Research, London, UK. ^[3] Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. ^[4] The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK. ^[5] Oxford University Hospitals NHS Foundation Trust, Oxford, UK. ^[6] Epsom and St Helier University Hospitals NHS Trust, Carshalton, UK. ^[7] University of Bristol, Bristol, UK. ^[8] Royal Free London NHS Foundation Trust, London, UK. ^[9] South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK. ^[10] The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. ^[11] Stockport NHS Foundation Trust, Stockport, UK. ^[12] Dartford and Gravesham NHS Trust, Dartford, UK. ^[13] Dorset County Hospital NHS Foundation Trust, Dorchester, UK. ^[14]

医学主题词投药, 膀胱内(Administration, Intravesical);老年人(Aged);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡介苗(BCG Vaccine);癌, 移行细胞(Carcinoma, Transitional Cell);心血管疾病(Cardiovascular Diseases);环氧化酶2抑制剂(Cyclooxygenase 2 Inhibitors);疾病恶化(Disease Progression);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);丝裂霉素(Mitomycin);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);生活质量(Quality of Life);危险性评估(Risk Assessment);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome);膀胱肿瘤(Urinary Bladder Neoplasms)

DOI 10.1016/j.eururo.2018.09.020

PMID 30279015

发布时间 2025-05-30

检索历史清除

BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004).

European urology

相似文献

同项目论文

European urology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004).

European urology

相似文献

同项目论文

European urology

相关期刊

检索历史清除